ET-traps Overview
- Status
- Private
- Latest Deal Type
- Accelerator/Inc
- Latest Deal Amount
- $100K
- Investors
- 2
ET-traps General Information
Description
Developer of endothelin-1 traps. The company develops endothelin-1 traps which are antibody-based fusion proteins that could bind and sequester the increased levels of endothelin-1 found in different diseases.
Contact Information
Website
Formerly Known As
EndoTraps
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Primary Office
- England, United Kingdom
ET-traps Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | $100K | 00000 | Completed | Startup | ||
| 1. Accelerator/Incubator | 12-Apr-2015 | Completed | Startup |
ET-traps Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Helene Fox | Co-Founder |
ET-traps Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Accelerate Cambridge | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Founder.org | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |